Keyword

giredestrant

Description: Giredestrant is an oral selective estrogen receptor degrader studied as an endocrine therapy for estrogen receptor-positive breast cancer.
Wikidata ID: wiki/Q131198690
OpenAlex ID: keywords/giredestrant
2021 · Ya-Chi Chen, Jiajie Yu, et al. · Expert Opinion on Investigational Drugs · 85
2024 · M. T. Herrera-Abreu, J. Guan, et al. · Nature Communications · 55
2024 · Giorgio Guglielmi, Marzia Del Re, et al. · European Journal of Pharmacology · 41
2024 · Mathilde Gheysen, Kevin Punie, et al. · Cancer Treatment Reviews · 37
2022 · Isabel Garcia-Fructuoso, Raquel Gomez-Bravo, et al. · Current Opinion in Oncology · 27
2022 · Jackson Liang, Ellen Rei Ingalla, et al. · Science Translational Medicine · 22
Works count: 156
Citation count: 1,193
Year
Topic
Type